BREAST INFLAMMATORY CARCINOMA
Clinical trials for BREAST INFLAMMATORY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BREAST INFLAMMATORY CARCINOMA trials appear
Sign up with your email to follow new studies for BREAST INFLAMMATORY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to stop rare breast Cancer's return
Disease control OngoingThis study tests whether adding the targeted drug olaparib to standard radiation therapy helps prevent inflammatory breast cancer from coming back. About 300 patients who have already had chemotherapy and mastectomy will be randomly assigned to receive radiation with or without o…
Matched conditions: BREAST INFLAMMATORY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:17 UTC
-
Immunotherapy combo offers new hope for tough breast cancer cases
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to hormone therapy and radiation can help prevent recurrence in people with hormone receptor-positive inflammatory breast cancer. Participants had chemotherapy before surgery, but their cancer did not completely…
Matched conditions: BREAST INFLAMMATORY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:54 UTC